MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

Summary: Advanced prostate cancers are treated with therapies targeting the androgen receptor (AR) signaling pathway. While many tumors initially respond to AR inhibition, nearly all develop resistance. It is critical to understand how prostate tumor cells respond to AR inhibition in order to exploi...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Preston D. Crowell, Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt, Anton Petcherski, Raag Agrawal, Matthew J. Bernard, Johnny A. Diaz, Kylie Y. Heering, Rong Rong Huang, Jin-Yih Low, Nedas Matulionis, Nora M. Navone, Huihui Ye, Amina Zoubeidi, Heather R. Christofk, Matthew B. Rettig, Robert E. Reiter, Michael C. Haffner, Paul C. Boutros, Orian S. Shirihai, Ajit S. Divakaruni, Andrew S. Goldstein
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Elsevier 2023-10-01
Cyfres:Cell Reports
Pynciau:
CP: Cancer
CP: Metabolism
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2211124723012330

Rhyngrwyd

http://www.sciencedirect.com/science/article/pii/S2211124723012330

Eitemau Tebyg